The Blood Testing Market is expected to exceed more than US$ 66.20 Billion by 2028 at a CAGR of 2.5% in the given forecast period.
A blood test is a laboratory examination system of logical nature of a blood sample, as a rule for the analysis of disease or discovery or estimation of the degree of substances or cells.
Blood tests give a wide scope of screening, checking and symptomatic capacities that prepare for medication disclosure and the structure of new treatment plans.
The rise in point-of-care testing is required to proceed with the advancement of more up to date advances that incorporate the precision of lab testing with the comfort of self-monitoring.
Blood tests that may cause leaps forward in the analysis of infections are being created, for instance, tests that can identify different diseases and cancers from a single drop of blood.
Blood testing for oncology is one of the most quickly growing fields in the market, with the innovation of companion diagnostics and precision drugs adding to development
The global Blood Testing Market is segregated on the basis of Method as Automated Blood Testing and Manual Blood Testing. Based on Type the global Blood Testing Market is segmented in Liver Function test, Complete Blood Count (CBC), Lipid profile, Blood Glucose, Blood Culture tests, Biochemical tests, Staining, Kidney function tests, Cardiac Function tests, and Other. Based on End-User Industry the global Blood Testing Market is segmented in Hospitals, Research Labs, Blood Banks, Pathology Labs, Clinics, and Other.
Based on Technology, the global Blood Testing Market is segmented in Immunofluorescence assay (IFA), Next generation sequencing (NGS), Western Blotting, Radioimmunoprecipitation assay (RIPA), Nucleic acid amplification test (NAT), Enzyme immunoassay (EIA), Enzyme linked immunosorbent assay (ELISA), and Chemiluminescent immunoassay (CLIA).
The global Blood Testing Market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Blood Testing Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Thermo Fisher Scientific, Novartis International AG, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Biomerica Inc, BioMerieux SA, Cepheid Corporation, Abbott Laboratories, BioRad Laboratories, Baxter International, and others are among the major players in the global Blood Testing Market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Blood Testing Market has been segmented as below:
Blood Testing Market, By Method
Blood Testing Market, By Type
Blood Testing Market, By End-User Industry
Blood Testing Market, By Technology
Blood Testing Market, By Region
Blood Testing Market, By Company
The report covers:
Report Scope:
The global Blood Testing Market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level Market dynamics. The scope also covers competitive overview providing company Market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering Market shares and profiles key participants in the global Blood Testing Market share. Major industry players with significant revenue share include Thermo Fisher Scientific, Novartis International AG, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Biomerica Inc, BioMerieux SA, Cepheid Corporation, Abbott Laboratories, BioRad Laboratories, Baxter International, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Overactive Bladder Treatment Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Blood Testing Market, By Method
5.1 Introduction
5.2 Automated Blood Testing
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Manual Blood Testing
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Blood Testing Market, By Type
6.1 Introduction
6.2 Liver Function test
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Complete Blood Count (CBC)
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Lipid profile
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Blood Glucose
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Blood Culture tests
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Biochemical tests
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 Staining
6.8.1 Market Overview
6.8.2 Market Size and Forecast
6.9 Kidney function tests
6.9.1 Market Overview
6.9.2 Market Size and Forecast
6.10 Cardiac Function tests
6.10.1 Market Overview
6.10.2 Market Size and Forecast
6.11 Other
6.11.1 Market Overview
6.11.2 Market Size and Forecast
7. Blood Testing Market, By End-User Industry
7.1 Introduction
7.2 Hospitals
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Research Labs
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Blood Banks
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Pathology Labs
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Clinics
7.6.1 Market Overview
7.6.2 Market Size and Forecast
7.7 Other
7.7.1 Market Overview
7.7.2 Market Size and Forecast
8. Blood Testing Market, By Technology
8.1 Introduction
8.2 Immunofluorescence assay (IFA)
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Next generation sequencing (NGS)
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Western Blotting
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Radioimmunoprecipitation assay (RIPA)
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Nucleic acid amplification test (NAT)
8.6.1 Market Overview
8.6.2 Market Size and Forecast
8.7 Enzyme immunoassay (EIA)
8.7.1 Market Overview
8.7.2 Market Size and Forecast
8.8 Enzyme linked immunosorbent assay (ELISA)
8.8.1 Market Overview
8.8.2 Market Size and Forecast
8.9 Chemiluminescent immunoassay (CLIA)
8.9.1 Market Overview
8.9.2 Market Size and Forecast
9. Blood Testing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Blood Testing, By Method
9.2.2 North America Blood Testing, By Type
9.2.3 North America Blood Testing, By End-User Industry
9.2.4 North America Blood Testing, By Technology
9.3 Europe
9.3.1 Europe Blood Testing, By Method
9.3.2 Europe Blood Testing, By Type
9.3.3 Europe Blood Testing, By End-User Industry
9.3.4 Europe Blood Testing, By Technology
9.4 Asia-Pacific
9.4.1 Asia-Pacific Blood Testing, By Method
9.4.2 Asia-Pacific Blood Testing, By Type
9.4.3 Asia-Pacific Blood Testing, By End-User Industry
9.4.4 Asia-Pacific Blood Testing, By Technology
9.5 Rest of the World
9.5.1 Rest of the World Blood Testing, By Method
9.5.2 Rest of the World Blood Testing, By Type
9.5.3 Rest of the World Blood Testing, By End-User Industry
9.5.4 Rest of the World Blood Testing, By Technology
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Novartis International AG
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 F. Hoffmann-La Roche AG
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Becton, Dickinson and Company
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Biomerica Inc
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 BioMerieux SA
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Cepheid Corporation
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Abbott Laboratories
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 BioRad Laboratories
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Baxter International
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
The Blood Testing Market has been segmented as below:
Blood Testing Market, By Method
Blood Testing Market, By Type
Blood Testing Market, By End-User Industry
Blood Testing Market, By Technology
Blood Testing Market, By Region
Blood Testing Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
